Advertisement
''We will be showcasing two new products at the RSNA Conference, includingour portable M5 and DC-3 diagnostic ultrasound systems,'' said Mr. Xu Hang,Mindray's chairman and co-chief executive officer. "The high-functionality,competitively-priced M5 is our first portable color ultrasound imaging systemand is tailored for North American and European markets. We are also excitedto introduce our color DC-3 diagnostic ultrasound system, which holdssignificant market potential in China and in developing markets around theworld.''
Advertisement
The company expects to launch both the DC-3 and portable M5 diagnosticultrasound systems globally at the end of 2007, excluding the U.S. In theU.S., the products will be launched as soon as they receive U.S. Food andDrug Administration (FDA) 510k clearance.
Mr. Minghe Cheng, Mindray's executive vice president of strategicdevelopment and Mr. Jie Liu, Mindray's executive vice president ofinternational sales & marketing will attend the event.
About Mindray
Mindray Medical International Limited is a leading developer, manufacturerand marketer of medical devices in China with a significant and growingpresence worldwide. Established in 1991, Mindray offers a broad range ofproducts across three primary business segments: patient monitoring devices,diagnostic laboratory instruments, and ultrasound imaging systems. Mindray isheadquartered in Shenzhen, China, and has 29 local sales and service officesin China, as well as sales and service offices in Amsterdam, Boston, Istanbul,London, Mexico City, Mumbai, Sao Paulo, Seattle, Toronto and Vancouver. Formore information, please visit http://www.mindray.com .
Safe Harbor Statement
This announcement contains forward-looking statements. These statementsare made under the ''safe harbor'' provisions of the U.S. Private SecuritiesLitigation Reform Act of 1995. These forward-looking statements can beidentified by terminology such as ''will,'' ''expects,'' ''anticipates,''''future,'' ''intends,'' ''plans,'' ''believes,'' ''estimates,'' ''confident''and similar statements. Statements that are not historical facts, includingstatements about Mindray's beliefs and expectations, are forward-lookingstatements. Forward-looking statements involve inherent risks anduncertainties. Information regarding these risks and uncertainties isincluded in our public filings with the Securities and Exchange Commission.All information provided in this press release is as of November 21, 2007, andMindray undertakes no duty to update such information, except as requiredunder applicable law.The company will exhibit the following products at the RSNA Conference: M5 Diagnostic Ultrasound System DC-3 Diagnostic Ultrasound System DP-9900 Digital Ultrasonic Diagnostic Imaging System DP-8800 Plus Digital Ultrasonic Diagnostic Imaging System DP-7700 Digital Ultrasonic Diagnostic Imaging System DP-6600 Digital Ultrasonic Diagnostic Imaging System DP-3300 Digital Ultrasonic Diagnostic Imaging System DP-6600 VET Diagnostic Imaging System DC-6 Diagnostic Ultrasound System DC-6 Expert Diagnostic Ultrasound System DP-2200 Ultrasonic Diagnostic Imaging System For additional information, please see http://rsna2007.rsna.org .
SOURCE Mindray Medical International Limited
